Insider plans sale of 8,078 NCNO shares

A shareholder in NCNO has filed a Rule 144 notice to sell 8,078 common shares through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $150,915.62.

Rhea-AI Filing Summary

A shareholder in NCNO has filed a Rule 144 notice to sell 8,078 common shares through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $150,915.62. The issuer had 114,684,968 common shares outstanding at the time of the notice.

The shares to be sold were acquired on 02/02/2026 via restricted stock vesting from the issuer as compensation. The same shareholder previously sold 4,731 common shares on 11/04/2025 for gross proceeds of $122,119.88, showing an ongoing program of stock sales under Rule 144.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the NCNO Form 144 filing by April Rieger disclose?

The Form 144 shows a planned sale of 8,078 NCNO common shares worth $150,915.62 on NASDAQ. The shares were acquired via restricted stock vesting as compensation on 02/02/2026, and will be sold through Fidelity Brokerage Services LLC.

How many NCNO shares are being sold under this Form 144?

The filing covers a proposed sale of 8,078 NCNO common shares. These shares have an aggregate market value of $150,915.62. The sale is planned to occur on or around 02/03/2026 on the NASDAQ exchange through Fidelity Brokerage Services.

How were the NCNO shares in this Form 144 acquired?

The 8,078 NCNO common shares were acquired on 02/02/2026 through restricted stock vesting from the issuer. The filing labels the nature of payment as compensation, indicating these shares were granted as part of an equity compensation arrangement rather than purchased for cash.

What prior NCNO share sales by this seller are disclosed?

The filing reports a prior sale of 4,731 NCNO common shares on 11/04/2025, generating gross proceeds of $122,119.88. This historical sale information is required so that Rule 144 can aggregate sales over the past three months for volume compliance.

How many NCNO shares were outstanding when this Form 144 was filed?

The Form 144 states there were 114,684,968 NCNO common shares outstanding. This figure helps place the planned 8,078-share sale in context relative to the issuer’s total equity base and supports the Rule 144 volume limitation calculations for resales.

Which broker and exchange will handle the NCNO Form 144 sale?

The proposed sale will be executed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. The filing specifies that the 8,078 NCNO common shares are expected to be sold on the NASDAQ stock market on or about 02/03/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:19 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001928630
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	nCino, Inc.
SEC File Number	001-41211
Address of Issuer	6770 PARKER FARM DRIVE WILMINGTON NORTH CAROLINA 28405
Phone	910-275-5491
Name of Person for Whose Account the Securities are To Be Sold	Rieger April
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8078	150915.62	114684968	02/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/02/2026	Restricted Stock Vesting	Issuer			8078	02/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
April Rieger 6770 Parker Farm Drive Wilmington NC 28405	Common	11/04/2025	4731	122119.88

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for April Rieger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)